Co-Authors
This is a "connection" page, showing publications co-authored by LAXMAN DEVKOTA and ANANTH ANNAPRAGADA.
Connection Strength
1.144
-
Feasibility Study of Ferumoxtyol for Contrast-enhanced MRI of Retroplacental Clear Space Disruption in Placenta Accreta Spectrum (PAS). medRxiv. 2023 Mar 24.
Score: 0.223
-
A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imaging. Theranostics. 2022; 12(12):5504-5521.
Score: 0.212
-
Detection of response to tumor microenvironment-targeted cellular immunotherapy using nano-radiomics. Sci Adv. 2020 07; 6(28):eaba6156.
Score: 0.185
-
Pre-clinical magnetic resonance imaging of retroplacental clear space throughout gestation. Placenta. 2019 02; 77:1-7.
Score: 0.167
-
A Hyperfluorinated Hydrophilic Molecule for Aqueous 19F MRI Contrast Media. Contrast Media Mol Imaging. 2018; 2018:1693513.
Score: 0.165
-
Nanoparticle Contrast-enhanced MRI for Visualization of Retroplacental Clear Space Disruption in a Mouse Model of Placental Accreta Spectrum (PAS). Acad Radiol. 2023 Jul; 30(7):1384-1391.
Score: 0.054
-
Early Detection of Aortic Degeneration in a Mouse Model of Sporadic Aortic Aneurysm and Dissection Using Nanoparticle Contrast-Enhanced Computed Tomography. Arterioscler Thromb Vasc Biol. 2021 04; 41(4):1534-1548.
Score: 0.048
-
Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's disease. Sci Rep. 2020 09 30; 10(1):16185.
Score: 0.047
-
Nanoparticle Contrast-enhanced T1-Mapping Enables Estimation of Placental Fractional Blood Volume in a Pregnant Mouse Model. Sci Rep. 2019 12 10; 9(1):18707.
Score: 0.044